Evidence map›Paper›PMID 38534395›Full record

ArticleCells2024

IF1 Promotes Cellular Proliferation and Inhibits Oxidative Phosphorylation in Mouse Embryonic Fibroblasts under Normoxia and Hypoxia.

Lothar Lauterboeck, Sung Wook Kang, Donnell White, Rong Bao, Parnia Mobasheran, Qinglin Yang

Open access · goldAbstract read
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lothar LauterboeckCardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.ORCID 0000-0001-5606-1767
Sung Wook KangCardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
Donnell WhiteCardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.ORCID 0000-0002-5368-3752
Rong BaoCardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
Parnia MobasheranCardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.
Qinglin YangCardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.ORCID 0000-0002-6024-2517
Louisiana State University Health Sciences Center New Orleans · USThermo Fisher Scientific (United States) · US

Funding

Energetic State and Metabolic Remodeling in Cardiac Hypertrophy and FailureR01HL160969 · NHLBI · LSU HEALTH SCIENCES CENTER · PI YANG, QINGLIN · 2022 to 2025
$1.9M
Improving Mitochondrial Function to Protect against Myocardial Ischemia/ReperfusionR01HL135336 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI YANG, QINGLIN · 2017 to 2020
$1.5M
NHLBI NIH HHS R01 HL135336NHLBI NIH HHS R01 HL160969NIH HHS R01HL135336NIH HHS R01HL160969
6 · The paper itself

Abstract

ATP synthase inhibitory factor subunit 1 (IF1) is an inhibitory subunit of mitochondrial ATP synthase, playing a crucial role in regulating mitochondrial respiration and energetics. It is well-established that IF1 interacts with the F1 sector of ATP synthase to inhibit the reversal rotation and, thus, ATP hydrolysis. Recent evidence supports that IF1 also inhibits forward rotation or the ATP synthesis activity. Adding to the complexity, IF1 may also facilitate mitophagy and cristae formation. The implications of these complex actions of IF1 for cellular function remain obscure. In the present study, we found that IF1 expression was markedly upregulated in hypoxic MEFs relative to normoxic MEFs. We investigate how IF1 affects cellular growth and function in cultured mouse embryonic fibroblasts derived from mouse lines with systemic IF1 overexpression and knockout under normoxia and hypoxia. Cell survival and proliferation analyses revealed that IF1 overexpression exerted limited effects on cellular viability but substantially increased proliferation under normoxia, whereas it facilitated both cellular viability and proliferation under hypoxia. The absence of IF1 may have a pro-survival effect but not a proliferative one in both normoxia and hypoxia. Cellular bioenergetic analyses revealed that IF1 suppressed cellular respiration when subjected to normoxia and was even more pronounced when subjected to hypoxia with increased mitochondrial ATP production. In contrast, IF1 knockout MEFs showed markedly increased cellular respiration under both normoxia and hypoxia with little change in mitochondrial ATP. Glycolytic stress assay revealed that IF1 overexpression modestly increased glycolysis in normoxia and hypoxia. Interestingly, the absence of IF1 in MEFs led to substantial increases in glycolysis. Therefore, we conclude that IF1 mainly inhibits cellular respiration and enhances cellular glycolysis to preserve mitochondrial ATP. On the other hand, IF1 deletion can significantly facilitate cellular respiration and glycolysis without leading to mitochondrial ATP deficit.

Indexed as

Oxidative PhosphorylationProteinsAdenosine TriphosphateAnimalsCell ProliferationFibroblastsHyperplasiaHypoxiaMiceAdenosine TriphosphateProteinsATPATP synthase inhibitory factor subunit 1cell proliferationcellular glycolysiscellular respirationcellular viabilitymitochondriamouse embryonic fibroblasts

Identifiers

PMID38534395
PMCPMC10969582
OpenAlexW4393043536

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.